A client on peritoneal dialysis is experiencing abdominal pain and fever. Which of the following actions should the nurse take first?
Administer an analgesic for the abdominal pain.
Measure the client's blood pressure and pulse rate.
Check the catheter for kinks or obstructions.
Notify the healthcare provider about the symptoms.
The Correct Answer is C
A) This statement is incorrect. Administering an analgesic for the abdominal pain may provide temporary relief, but it does not address the underlying cause of the symptoms.
B) This statement is incorrect. Measuring blood pressure and pulse rate is essential for client assessment, but it may not provide enough information to determine the cause of the symptoms.
C) This statement is accurate. Abdominal pain and fever in a client on peritoneal dialysis may indicate peritonitis, which can result from infection or catheter issues. The nurse should first check the catheter for kinks or obstructions to ensure proper drainage and prevent complications.
D) This statement is incorrect. Notifying the healthcare provider about the symptoms is important, but the nurse should first assess the catheter for possible issues to determine if immediate intervention is needed.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is B
Explanation
A) This statement is incorrect. Hemodialysis does not involve the removal of the peritoneal membrane; that description is characteristic of peritoneal dialysis.
B) This statement is accurate. Hemodialysis uses a machine called a dialyzer to filter blood outside the body, removing waste products and excess fluid before returning the clean blood to the patient.
C) This statement is incorrect. Hemodialysis does not rely on a catheter inserted into the bladder; that description is characteristic of urinary catheterization.
D) This statement is incorrect. Hemodialysis does not use a pump to circulate dialysate through the intestines; that description is characteristic of peritoneal dialysis.
Correct Answer is B
Explanation
A) This statement is incorrect. Erythropoietin-stimulating agents (ESAs) are not used to prevent infections during dialysis. They are used to address anemia by stimulating red blood cell production.
B) This statement is accurate. Erythropoietin-stimulating agents (ESAs) stimulate the bone marrow to produce more red blood cells, addressing anemia commonly associated with chronic kidney disease and dialysis.
C) This statement is incorrect. Erythropoietin-stimulating agents (ESAs) do not reduce the risk of blood clot formation. They are specific to stimulating the production of red blood cells.
D) This statement is incorrect. Erythropoietin-stimulating agents (ESAs) do not enhance kidney function and filtration. They target the production of red blood cells to address anemia associated with ESRD and dialysis.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.